MetaTrader
  • Märkte
  • Charts & Ideen
  • Algo
  • Nachrichten
  • Store
  • Broker
  • Herunterladen
  • Wirtschaftskalender
  • Handelssignale
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
Oric Pharmaceuticals, Inc. Common Stock

ORIC

#1990
Oric Pharmaceuticals, Inc. Common Stock
13.4500
+4.59%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
13.4500
13.4500
Jahresspanne
7.8400
14.2480
Tagesänderung
+4.59%
Monatliche Änderung
+11.80%
6 month change
-0.44%
Jahresänderung
-0.44%
Vorheriger Schlusskurs
12.8600
Open
13.4500
Bid
Ask
Low
13.4500
High
13.4500
Volumen
173
  1. Märkte
  2. Aktien
  3. Gesundheitswesen
  4. ORIC
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Nachrichten

Investing Investing
ORIC
2026.02.25
H.C. Wainwright, ORIC Pharmaceuticals için hedef fiyatı yükseltti
Investing Investing
ORIC
2026.02.25
H.C. Wainwright raises ORIC Pharmaceuticals price target on trial progress
Investing Investing
ORIC
2026.02.24
Oppenheimer ORIC hissesi için Outperform tavsiyesini tekrarladı
Investing Investing
ORIC
2026.02.24
Oppenheimer reiterates Outperform on ORIC stock, $15 target
Investing Investing
ORIC
2026.02.23
Oric Pharmaceuticals 200 milyon dolarlık yeni halka arz başvurusu yaptı
Investing Investing
ORIC
2026.02.23
Oric Pharmaceuticals files new $200 million at-the-market offering prospectus
Investing Investing
ORIC
2026.01.21
Oric Pharmaceuticals yöneticisi Heyman 80.430 dolar değerinde hisse satışı gerçekleştirdi
Investing Investing
ORIC
2026.01.21
Oric Pharmaceuticals director Heyman sells shares worth $80,430
Seeking Alpha Seeking Alpha
ORIC
2026.01.20
ORIC: Transition To Late-Stage Development Presents Upside (NASDAQ:ORIC)
Investor's Business Daily Investor's Business Daily
ORIC GMAB HALO KRYS
2026.01.15
Oric Pharmaceuticals Stock Sees Healthy RS Rating Jump To 80
Investing Investing
ORIC
2026.01.15
H.C. Wainwright, ORIC Pharmaceuticals hissesi için Al tavsiyesini yineliyor
Investing Investing
ORIC
2026.01.15
H.C. Wainwright reiterates Buy rating on ORIC Pharmaceuticals stock

Märkte

  • Aktien
  • Währungen
  • Kryptowährungen
  • Metalle
  • Rohstoffe

Charts & Ideen

  • Handelsideen
  • Aufbildungsideen
  • Charts

MQL5 Community

  • Market
  • Signale
  • Forum
  • Artikel
  • CodeBase

Nachrichten

  • Aktien
  • Währungen
  • Kryptowährungen
  • Metalle
  • Rohstoffe

Broker

  • Alle Broker
  • Forex
  • Aktien
  • Metalle
MetaTrader 5
MQL5 Channels
Economic Calendar
Haftungsausschluss und Risikohinweis Nutzungsbedingungen Kontakt Rechtliche Hinweise
Copyright 2000-2026, MetaQuotes Ltd